---
title: "Sonic Healthcare Limited (SHL) Receives a Hold from Ord Minnett"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296564561.md"
description: "Ord Minnett maintained a Hold rating on Sonic Healthcare Limited (SHL) with a price target of A$20.80. UBS's David Low also issued a Hold rating, while Morgan Stanley maintained a Sell rating on the stock."
datetime: "2026-08-21T02:05:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296564561.md)
  - [en](https://longbridge.com/en/news/296564561.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296564561.md)
generator: "portal-rs"
---

# Sonic Healthcare Limited (SHL) Receives a Hold from Ord Minnett

In a report released today, from Ord Minnett maintained a Hold rating on Sonic Healthcare Limited, with a price target of A$20.80.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In addition to Ord Minnett, Sonic Healthcare Limited also received a Hold from UBS’s David Low in a report issued today. However, on the same day, Morgan Stanley maintained a Sell rating on Sonic Healthcare Limited (ASX: SHL).

### Related Stocks

- [SHL.AU](https://longbridge.com/en/quote/SHL.AU.md)

## Related News & Research

- [Morgan Stanley Reaffirms Their Sell Rating on Sonic Healthcare Limited (SHL)](https://longbridge.com/en/news/296559134.md)
- [Sonic Healthcare FY26 underlying net profit rises 17% to A$ 621 million; revenue climbs 13% to A$ 10.87 billion](https://longbridge.com/en/news/296423084.md)
- [RBC Capital Keeps Their Buy Rating on North West (NWC)](https://longbridge.com/en/news/298601213.md)
- [Jefferies Sticks to Its Hold Rating for Corporate Travel Management Limited (CTMLF)](https://longbridge.com/en/news/298941156.md)
- [Citi Keeps Their Buy Rating on Challenger  (CFIGF)](https://longbridge.com/en/news/298847281.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**